Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Survey Aims To Quantify Cost Of Physician-Payment Tracking Requirements

This article was originally published in The Gray Sheet

Executive Summary

A recent 1survey shows that upwards of 40% of device and drug firms spend over $500,000 capturing, tracking and reporting payments to health care professionals each year to comply with various state reporting requirements

You may also be interested in...



Vermont May Be State Number Two With A Device Firm Disclosure Mandate

If Vermont Governor Jim Douglas signs a bill that was sent to his desk earlier this month, his state will be the second in the country to impose on medical device companies a physician gift ban and a disclosure requirement for payments made to doctors

Massachusetts Finalizes Stricter Marketing Requirements

Device and drug manufacturers have until July 1 to comply with the final regulations that implement a Massachusetts device and pharmaceutical marketing law

China VBP, Localization And Other Strategies - How Far And Which Way?

Could health sector players encounter issues similar to those facing Tesla in China, a country which virtually saved the electric vehicle maker but where it is now facing challenges? Are there any lessons to be learned from a success story under China's volume-based procurement scheme? A partner at EY looks at these and other issues in an interview with Scrip.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT028284

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel